Inspira’s ART100 System Gains Approval for Organ Transplant Use in Israel

An announcement from Inspira Technologies Oxy BHN ( (IINN) ) is now available.

On May 7, 2025, Inspira Technologies announced that its INSPIRA ART100 system has been approved by Israel’s largest healthcare provider for clinical validation in organ transplant procedures. This approval allows the system to be used by leading physicians at a renowned medical center, offering a unique opportunity to gather insights on its performance in complex transplantation environments. The data collected will support the development of the INSPIRA ART500 system, which aims to advance respiratory care. This development marks a significant milestone for Inspira, enhancing its industry positioning and potentially impacting stakeholders by demonstrating the system’s capabilities in critical medical applications.

Spark’s Take on IINN Stock

According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.

The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.

To see Spark’s full report on IINN stock, click here.

More about Inspira Technologies Oxy BHN

Inspira Technologies Oxy B.H.N. Ltd. is a company focused on developing innovative respiratory support and diagnostic technologies. Their flagship product, the INSPIRA ART500 system, aims to revolutionize critical care by enabling patients to remain awake during treatment while stabilizing oxygen levels without mechanical ventilation. The company also offers the FDA-cleared INSPIRA ART100 system, which has received regulatory approvals for cardiopulmonary bypass procedures in the U.S. and Israel. Additionally, Inspira is developing the HYLA blood sensor technology for continuous, real-time blood monitoring.

Average Trading Volume: 699,698

Technical Sentiment Signal: Sell

Current Market Cap: $14.99M

See more data about IINN stock on TipRanks’ Stock Analysis page.